Control of Type II Transforming Growth Factor-β Receptor Expression by Integrin Ligation
Open Access
- 1 April 1999
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 274 (18), 12840-12847
- https://doi.org/10.1074/jbc.274.18.12840
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cross-talk between Insulin Receptor and Integrin α5β1 Signaling PathwaysJournal of Biological Chemistry, 1998
- Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cellsJournal of Cellular Physiology, 1998
- Induction of Transforming Growth Factor-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cells through SP1 Activation by 5-Aza-2′-deoxycytidinePublished by Elsevier BV ,1998
- Defects of TGF-β receptor signaling in mammary cell tumorigenesisJournal of Mammary Gland Biology and Neoplasia, 1996
- Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma CellsPublished by Elsevier BV ,1996
- Release from quiescence stimulates the expression of integrin α5β1 which regulates DNA synthesis in human fibrosarcoma HT1080 cellsJournal of Cellular Physiology, 1995
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Expression and function of VLA‐α2, ‐α3, ‐α5 and ‐α6‐integrin receptors in pancreatic carcinomaInternational Journal of Cancer, 1992
- Modulation of growth factor responsiveness of murine mammary carcinoma cells by cell matrix interactions: Correlation of cell proliferation and spreadingJournal of Cellular Physiology, 1992
- Preparation and binding of radioactively labeled porcine transforming growth factor type βBiochemical and Biophysical Research Communications, 1986